USP22 and colonic neoplasm: In HCT116 colon cancer cells, knocking down USP22 weakens the protein stability of PD‐L1 and resulted in a shorter half‐life, alone with attenuated resistance to T‐cell cytotoxicity (Figure4A–C; Figure S4A, Supporting Information).